ARTICLE | Company News
BTG, Wellstat Therapeutics sales and marketing update
July 11, 2011 7:00 AM UTC
Wellstat granted BTG exclusive, U.S. rights to commercialize uridine triacetate to treat an overdose of the chemotherapy 5-fluorouracil (5-FU). Wellstat will be responsible for regulatory filings in ...